FOLH1 and prostate carcinoma: In the PSMA-PET, the uptake of the prostate carcinoma was SUVmax 55.5 and the suspected liver metastasis was SUVmax 106.2; no uptake was seen in the neuroendocrine primary tumor and only faint uptake (SUVmax 8.5) in a peritoneal lymph node.